Literature DB >> 1125836

A pharmacological study of chloramphenicol in horses.

C S Sisodia, L L Kramer, V S Gupta, D J Lerner, L Taksas.   

Abstract

Pharmacological disposition of chloramphenicol was studied in horses. Minimum levels of the antibiotic (greater than or equal to 5 mu g/ml) in blood or plasma recommended to combat infections could not be achieved by 4.4 and 8.8 mg/kg I.V. or 30 and 50 mg/kg I.M. or 30 mg/kg oral (as palmitate salt) doses of chloramphenicol. Increasing the dose to 19.8 and 26.4 mg/kg I.V. provided such levels for about two and three hours respectively. A combination of 20 mg/kg I.V. and 30 mg/kg I.M. administered simultaneously did not provide more prolonged levels than 26.4 mg/kg I.V. alone. Chloramphenicol succinate produced higher but not more prolonged levels in blood and plasma than those produced by pure chloramphenicol. Succinate salt is very little, if at all, bound to red blood corpuscles. Plasma half life and the apparent volume of distribution of chloramphenicol in horses were determined as 0.98 hours and 0.92 L/kg, respectively. At 5-10 mu g/ml concentrations in equine plasma approximately 30 percent of the chloramphenicol is bound to plasma proteins. From these studies it is concluded that the biological half life of chloramphenicol may be too short for therapeutic application against systemic infections in horses.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1125836      PMCID: PMC1277444     

Source DB:  PubMed          Journal:  Can J Comp Med        ISSN: 0008-4050


  11 in total

1.  THE BINDING OF SULFONAMIDE DRUGS BY PLASMA PROTEINS. A FACTOR IN DETERMINING THE DISTRIBUTION OF DRUGS IN THE BODY.

Authors:  B D Davis
Journal:  J Clin Invest       Date:  1943-09       Impact factor: 14.808

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Blood level studies in dogs following the administration of chloromycetin.

Authors:  F E EADS; A J GLAZKO; L M WOLF; J EHRLICH; M GALBRAITH
Journal:  Am J Vet Res       Date:  1952-04       Impact factor: 1.156

4.  Chloromycetin therapy in veterinary medicine.

Authors:  J W EASTMAN; A S SCHLINGMAN; M C MANNING; F E EADS
Journal:  J Am Vet Med Assoc       Date:  1952-01       Impact factor: 1.936

5.  A pharmacologic study of chloramphenicol in cattle.

Authors:  C S Sisodia; R H Dunlop; V S Gupta; L Taksas
Journal:  Am J Vet Res       Date:  1973-09       Impact factor: 1.156

6.  Chloramphenicol residues in tissues of broiler chickens.

Authors:  C S Sisodia; R H Dunlop
Journal:  Can Vet J       Date:  1972-11       Impact factor: 1.008

7.  Chloramphenicol concentrations in blood and milk of cows following parenteral administration.

Authors:  C S Sisodia; V S Gupta; R H Dunlop; O M Radostits
Journal:  Can Vet J       Date:  1973-09       Impact factor: 1.008

8.  Chloramphenicol plasma levels in the dog: a comparison of oral, subcutaneous and intramuscular administration.

Authors:  A D Watson
Journal:  J Small Anim Pract       Date:  1972-03       Impact factor: 1.522

9.  Chloramphenicol plasma levels in the dog: multiple oral and intramuscular administration.

Authors:  A D Watson
Journal:  J Small Anim Pract       Date:  1972-03       Impact factor: 1.522

10.  Distribution of chloramphenicol (chloromycetin) and its metabolic products between human red cells and plasma.

Authors:  A J GLAZKO; L M WOLF; W A DILL
Journal:  Proc Soc Exp Biol Med       Date:  1949-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.